Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
Search
 
My Lists

Metagenomi

1545 Park Avenue
Emeryville, CA 94608
USA
Website Company Summary Management Team
Management

CEO: Brian Thomas (9/30/2016)
General Management: Gregory Cost (12/31/2019)
Technology: Alan Brooks (11/30/2019)
Business Development: Christine Foster ; Jak Knowles
Board

Outside board: (May no longer be on the board) Andrew Farquharson (InCube Crowdfunding Managing Director) Jürg Eckhardt (Leaps by Bayer, Bayer Head);  Sebastian Bernales (UCSF Cell Biologist)
Company

Business description: At Metagenomi, we are accelerating innovation in cell and gene therapy with a wave of proprietary CRISPR-based systems to accurately edit DNA where current technologies cannot. Our metagenomics-powered discovery platform and analytical expertise reveal novel cellular machinery sourced from otherwise unknown organisms. We adapt and forge these naturally evolved systems into powerful therapeutic tools that can be leveraged by partners and fuel our own pipeline of potentially curative medicines. Our goal is to revolutionize gene editing and unlock its power for the benefit of patients around the world.
Capital

Rounds: 3
Recent Fundings: Jan 2022   Nov 2020
Capital raised: 264.40M
Last Round: 175.0M
Ownership: Private  
VCs include: InCube Ventures Sozo Ventures ;  VentureHealth;  HOF Capital ;  Agent Capital ;  Humboldt Fund Leaps by Bayer
Corporate investors: Bristol Myers Squibb;  Surveyor Capital

Last Tweets


 

Last Mentions


Overview
Record updated: Jan 2022
Sector: Biotech
Year Founded: 2018
Headcount: 101-150 as of May 2022
Rounds: 3
Recent Fundings: Jan 2022   Nov 2020
Capital Raised: 264.40M
Last Round: 175.0M
Ownership: Private